<strong>神经干细胞对胶质瘤发生发展影响的研究进展</strong>

摘要/Abstract

摘要：神经干细胞具有自我更新、不断增殖及多向分化的特性，以至在胶质瘤的发生和发展中产生重要的影响。胶质瘤的发生和发展是一个多步骤的复杂过程，涉及大量相关基因、转录因子、信号通路及其它们的相关蛋白，还有一些生长因子和酶等表达和调控的改变。

罗林明, 姜懿纳, 陈乃宏.神经干细胞对胶质瘤发生发展影响的研究进展[J]. 神经药理学报, 2015, 5(5): 28-33.

LUO Lin-ming, JI Yi-na, CHEN Nai-hong.Research Progress on the Effect of Neural Stem Cells in the Occurrence and Development of Glioma[J]. ACTA NEUROPHARMACOLOGICA, 2015, 5(5): 28-33.

[1] Gong Hai-dong, Zhang Zhe-nan, Hu Yong-zhen, et al. Research progress on miR-155 and glioma[J]. Progress in Modern Biomedicine, 2013, 13(35): 6994-6997.

[2] Timothy R Smith, M Maher Hulou, Josh Abecassis, et al. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin [J]. J Clin Neurosci, 2015, 22(9): 1397-1402.

[3] Raj S, Pandit P N, Kishor K. A retrospective comparative study of concomitant chemoradiotherapy followed by adjuvant temozolomide versus radiotherapy alone in newly diagnosed glioblastoma multiforme - an experience at radium institute, patna medical college and hospital, india [J]. Gulf J Oncolog, 2016, 1(20): 6-11.

[4] Ilker Y Eyüpoglu, Nirjhar Hore, Andreas Merkel, et al. Supra?complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma[J]. Oncotarget, 2016, (3): 1-14.

[5] Ursula Theocharidis, Katherine Long, Charles Ffrench-Constant, et al. Regulation of the neural stem cell compartment by extracellular matrix constituents [J]. Prog Brain Res, 2014, 214(4): 3-28.

[6] James C Marsh, Julie A Wendt, Arnold M Herskovic, et al. High-grade glioma relationship to the neural stem cell compartment: a retrospective review of 104 cases [J]. Int J Radiat Oncol Biol Phys, 2012, 82(2): e159-165.

[7] James C Marsh, Stewart Goldman, Ellis Ziel, et al. Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases [J]. J Neurooncol, 2015, 122(1): 105-110.

[8] James C Marsh, Aidnag Diaz, Richard Byrne, et al. Involvement of the neural stem cell compartment by low and high grade gliomas: a retrospective review of 80 low grade and 104 high grade tumors[J]. Fuel & Energy Abstracts, 2010, 78(3):S282-283.

[9] Lee Da Yong, Scott M Gianino, David H Gutmann. Innate neural stem cell heterogeneity determines the patterning of glioma formation in children [J]. Cancer Cell, 2012, 22(1): 131-138.

[10] Stefano Bartesaghi, Vincenzo Graziano, Sara Galavotti, et al. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells [J]. Proc Natl Acad Sci USA, 2015, 112(4): 1059-1064.

[11] Thomas S Jacques, Alexander Swales, Monika J Brzozowski, et al. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes [J]. Embo J, 2010, 29(1): 222-235.

[12] Hyo-Jung Park, Jun-Kyum Kim, Hye-Min Jeon, et al. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells [J]. Mol Cells, 2010, 30(5): 403-408.

[13] Liu Hai-kun, Wang Ying, Thorsten Belz, et al. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation [J]. Genes Dev, 2010, 24(7): 683-695.

[14] Liang Wang, Shiming He, Jun Yuan, et al. Oncogenic role of SOX9 expression in human malignant glioma[J]. Medical Oncology, 2012, 29(5): 3484-3490.

[15] Laura Garrosre-gulez, Paula Aldaz, Olatz Arrizabalaga, et al. mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance[J]. Expert Opinion on Therapeutic Targets, 2016, 20(4): 393-405.

[16] Fredrik J Swartling, Vasil Savov, Anders I Persson, et al. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC [J]. Cancer Cell, 2012, 21(5): 601-613.

[17] Liu Hong-wei, Liu Zhi-xiong, Jiang Bing, et al. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling[J]. Cell Biochemistry & Biophysics, 2015, 73(1): 1-8.

[18] Roman Bauer, Marcus Kaiser, Elizabeth Stoll. A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population [J]. PLoS One, 2014, 9(11): e111219.

[19] Severina Leu, Stefanie von Felten, Stephan Frank, et al. IDH mutation is associated with higher risk of malignant transformation in low-grade glioma[J]. J Neuro-Oncology, 2016, 127(2): 1-10.

[20] Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma [J]. Clin Cancer Res, 2013, 19(4): 764-772.

[21] Yuhua Zou, Wenze Niu, Song Qin, et al. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche[J]. Molecular & Cellular Biology, 2012, 32(23): 4811-4820.

[22] Mario Orozco-Morales, Francisco Javier Sánchez-García, Irene Golán-Cancela, et al. RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells[J]. Cancer Cell International, 2015, 15(1): 1-11.

[23] Liu Shuang, Yin Feng, Zhang Jian-ning, et al. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells [J]. J Cell Biochem, 2014, 115(8): 1368-1380.

[24] Ana L Morgado, Cecilia Rodrigues, Susana Solá. MicroRNA-145 regulates neural stem cell differentiation through the sox2-lin28/let-7 signaling pathway [J]. Stem Cells, 2016, (2): 2309.

[25] Sandhya B Rani, Sachin Shivaji Rathod, Shanmuganandam Karthik, et al. MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells[J]. Neuro-oncology, 2013, 15(10): 1302-1316.

[26] Li Xiao, Feng Rui-li, Chen Hai-feng, et al. MicroRNA-351 regulates TMEM 59 (DCF1) expression and mediates neural stem cell morphogenesis[J]. Rna Biology, 2012, 9(3): 292-301.

[27] Ulf Kahlert, Cheng Meng-lin, Katharina Koch, et al. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells[J]. International J Cancer, 2015, 138(5): 1246-1255.

[28] Xing Zhen-yi, Sun Lai-guang, Guo Wu-jun. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients[J]. Clinical Neurology & Neurosurgery, 2015, 131c: 54-58.

[29] 胡昳旸. Notch信号通路对胶质瘤干细胞作用的研究[D].西安：第四军医大学, 2012.

[30] Claudio Giachino, Jean-Louis Boulay, Robert Ivanek, et al. A tumor suppressor function for notch signaling in forebrain tumor subtypes[J]. Cancer Cell, 2015, 28(6): 730-742.

[31] 徐艳朋, 俞松. Ras信号传导通路与肿瘤的关系[J]. 遵义医学院学报, 2013, (03): 272-276.

[32] Joshua J Breunig, Rachelle Levy, C Danielle Antonuk, et al. Ets factors regulate neural stem cell depletion and gliogenesis in ras pathway glioma [J]. Cell Rep, 2015, 12(2): 258-271.

[33] Hee Jung Park, Hong Mingi, Roderick T Bronson, et al. Elevated id2 expression results in precocious neural stem cell depletion and abnormal brain development [J]. Stem Cells, 2013, 31(5): 1010-1021.

[34] 陈敢峰, 黄昕, 江亮, 等. 膜联蛋白A2和锌指转录因子Snail在人脑胶质瘤组织中的表达及意义[J]. 中华实验外科杂志, 2015, 32(1): 175-177.

[35] Yan Yu, Jiang Yu-gang. RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway[J]. J International Molecular Medicine, 2016, 37(1): 251-257.

[36] Li Hua, Chen Zhen-jun, Zhou Shao-peng. Apoptosis in glioma-bearing rats after neural stem cell transplantation [J]. Neural Regen Res, 2013, 8(19): 1793-1802.

[37] Patrick M Perrigue, Michael E Silva, Charles D Warden, et al. The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines [J]. Mol Cancer Res, 2015, 13(4): 636-650.

[38] Li Qiang, Wang Ai-Yue, Xu Qiong-Guan, et al. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma [J]. Int J Clin Exp Pathol, 2015, 8(10): 12234-12242.

[39] Molly E Boutin, Diane Hoffman-Kim. Application and assessment of optical clearing methods for imaging of tissue-engineered neural stem cell spheres [J]. Tissue Eng Part C Methods, 2015, 21(3): 292-302.

神经干细胞对胶质瘤发生发展影响的研究进展

Research Progress on the Effect of Neural Stem Cells in the Occurrence and Development of Glioma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

[1]	杨旭华, 杜爽, 沈丽霞, 郝军荣.阿尔茨海默病的药物治疗研究进展[J]. 神经药理学报, 2020, 10(3): 47-53.
[2]	张丽环, 楚宝, 张晓燕, 孙莹茹, 宫春东, 王贺波.镁在偏头痛发病机制及治疗中的研究进展[J]. 神经药理学报, 2020, 10(1): 29-33.
[3]	赵鹏慧，庞策，甄攀.桑皮素治疗脑胶质瘤的新思路[J]. 神经药理学报, 2019, 9(5): 44-49.
[4]	张林，蒋宁，周文霞，张永祥.疾病特异性诱导性多功能干细胞AD 模型建立[J]. 神经药理学报, 2018, 8(2): 54-54.
[5]	刘诺，王真真，陈乃宏.肠道菌群在阿尔茨海默病发病中的作用[J]. 神经药理学报, 2017, 7(5): 28-.
[6]	张力航，殷明.小分子化合物影响神经干细胞再生的思考[J]. 神经药理学报, 2017, 7(1): 1-9.
[7]	龙森，陈嘉烨，韩峰.童年孤独症发病机制及药物治疗进展[J]. 神经药理学报, 2016, 6(6): 55-64.
[8]	苏晓梅, 张丹参.Angiopep-2修饰的装载不同药物的纳米系统在胶质瘤中的应用[J]. 神经药理学报, 2015, 5(6): 57-63.
[9]	汪伦政，谢文娟，唐铁山.神经干细胞、成体神经发生以及神经变性疾病的细胞移植治疗[J]. 神经药理学报, 2015, 5(3): 46-64.
[10]	黄敏, 唐铁山, 郭彩霞.跨损伤DNA合成及其在肿瘤治疗中的应用[J]. 神经药理学报, 2014, 4(5): 36-43.
[11]	王真真, 陈乃宏.抑郁症与炎症[J]. 神经药理学报, 2013, 3(5): 27-37.
[12]	刘红彬, 武海霞.阿尔茨海默病的发病机制和动物模型研究进展[J]. 神经药理学报, 2013, 3(4): 14-22.
[13]	郝军荣，田玉琴，沈丽霞.神经胶质瘤药物治疗研究进展[J]. 神经药理学报, 2013, 3(3): 48-56.
[14]	郝军荣，沈丽霞.神经胶质瘤药物治疗的中药有效成分研究进展[J]. 神经药理学报, 2012, 2(5): 57-64.
[15]	茹琴,田香,陈琳,乐凯,马宝苗,李超英.大鼠神经胶质瘤和嗜铬细胞瘤中P2X受体的表达特征研究[J]. 神经药理学报, 2012, 2(4): 1-7.